IL6 and breast carcinoma: Blocking of IL-6 receptor with siRNA in breast cancer cells and neutralization of secreted IL-6 by adipocytes with neutralising IL-6 antibody, decreased the STAT3 phosphorylation and nuclear localization with decreased proliferation, migration and invasion capabilities of both breast cancer cell after co-culture (Fig. 5h–j).